DFFVX | MXTFX | DFFVX / MXTFX | |
Total Expense Ratio | 0.29 | 0.74 | 39% |
Annual Report Gross Expense Ratio | 0.30 | 0.74 | 41% |
Fund Existence | 26 years | 10 years | - |
Gain YTD | 3.910 | -1.031 | -379% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 13.3B | 602M | 2,209% |
Annual Yield % from dividends | 1.68 | 1.85 | 91% |
Returns for 1 year | 2.47 | -6.71 | -37% |
Returns for 3 years | 34.38 | 4.39 | 784% |
Returns for 5 years | 91.09 | 19.33 | 471% |
Returns for 10 years | 73.97 | -11.89 | -622% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XPH | 48.20 | 0.19 | +0.40% |
SPDR® S&P Pharmaceuticals ETF | |||
USML | 42.11 | N/A | N/A |
ETRACS 2x Lvrgd MSCI US Mn Vl Fct TR ETN | |||
AVSF | 47.29 | -0.03 | -0.06% |
Avantis Short-Term Fixed Income ETF | |||
IWN | 176.53 | -0.30 | -0.17% |
iShares Russell 2000 Value ETF | |||
FFDI | 29.96 | -0.11 | -0.37% |
Fidelity Fundamental Developed International ETF |